XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements
3 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
We measure fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Fair value measurements are based on a three tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets and liabilities; Level 2, defined as observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities or prices quoted in inactive markets; and Level 3, defined as unobservable inputs that are significant to the fair value of the asset or liability, and for which little or no market data exists, therefore requiring management to utilize its own assumptions to provide its best estimate of what market participants would use in valuing the asset or liability.

We did not have any material financial assets or liabilities measured at fair value on a recurring basis using Level 3 inputs as of June 30, 2022 or March 31, 2022. Our non-financial assets, such as goodwill, intangible assets and property and equipment, are measured at fair value on a nonrecurring basis, generally when there is a transaction involving those assets such as a purchase transaction, a business combination or an adjustment for impairment. No non-financial assets were measured at fair value at June 30, 2022 and March 31, 2022. As a result of the re-organization completed in April 2021, the Company reallocated goodwill to the three new reporting units discussed in Note 10, Business Segments. The contingent consideration representing Level 3 fair value measurement was prepared using the following assumptions:

Assumptions
Risk free rate0.14%
Counter party risk premium8.20%
Revenue WACC5.10%
Revenue volatility25.00%
The following tables present the Company’s financial assets that are recorded at fair value on a recurring basis, segregated among the appropriate levels within the fair value hierarchy:
As of June 30, 2022
(In thousands)
Amortized
Cost
Gross
Unrealized
Loss
Gross
Unrealized
Gain
Estimated Fair
Value
Assets:
Level 1:
Money market funds$1,280 $— $— $1,280 
Securities held in deferred compensation plan (1)
1,099 (142)75 1,032 
Subtotal2,379 (142)75 2,312 
Level 2:
US Treasuries2,400 — — 2,400 
Subtotal2,400 — — 2,400 
Total$4,779 $(142)$75 $4,712 
Liabilities:
Level 1:
Deferred compensation plan liabilities (2)
$1,102 $(146)$82 $1,038 
Subtotal1,102 (146)82 1,038 
Level 3:
Contingent consideration (3)
255 — — 255 
Subtotal255 — — 255 
Total$1,357 $(146)$82 $1,293 
As of March 31, 2022
(In thousands)
Amortized
Cost
Gross
Unrealized
Loss
Gross
Unrealized
Gain
Estimated Fair
Value
Assets:
Level 1:
Money market funds$71 $— $— $71 
Securities held in deferred compensation plan (1)
998 (106)73 965 
Subtotal1,069 (106)73 1,036 
Level 2:
Commercial paper7,499 — — 7,499 
US Treasuries7,798 — — 7,798 
Subtotal15,297 — — 15,297 
Total$16,366 $(106)$73 $16,333 
Liabilities:
Level 1:
Deferred compensation plan liabilities (2)
$1,013 $(106)$72 $979 
Subtotal1,013 (106)72 979 
Level 3:
Contingent consideration (3)
600 — — 600 
Subtotal600 — — 600 
Total$1,613 $(106)$72 $1,579 
(1) Included in prepaid expenses and other current assets on the Company’s balance sheet.
(2) Included in accrued payroll and related expenses on the Company’s balance sheet.
(3) Included short-term portion in accrued liabilities and long-term portion in other long-term liabilities on the Company’s balance sheet. As of June 30, 2022, the balance of contingent consideration was all short-term and included in accrued liabilities on the Company's balance sheet.

Unrealized losses related to investments are due to interest rate fluctuations as opposed to credit quality. In addition, we do not intend to sell, and it is not more likely than not that, we would be required to sell, any of our investments before recovery of their cost basis. As a result, there is no other-than-temporary impairment for these investments as of June 30, 2022.